Organ damage occurs in up to 70 percent of patients in the first few months following stem cell transplant. The precise reasons for this potentially life-threatening reaction have long been the subject of scientific research. Researchers led by Georg Stary from the Department of Dermatology at MedUni Vienna and Vienna General Hospital in collaboration with […]
Read More… from Skin microbiome identified as factor in stem cell transplants
Revolution in care of leukaemia as new treatment drug approved for cancer patients: Asciminib for Chronic myeloid leukaemia CML works differently to existing treatments, giving hope to patients who need a different approach. The charity Leukaemia Care today welcomes the news from the National Institute for Health and Care Excellence that a new cancer treatment […]
Read More… from Revolution in leukaemia care as new drug appoved
On World Cancer Day 2022 – ‘Turning Time‘ : A Richmond man has written about his experience ‘cheating cancer’ in a book he’s selling to raise funds for blood cancer charity Anthony Nolan. Richard Jefferies, 53, was diagnosed with myelodysplastic syndrome (MDS) a type of rare blood cancer ten years ago. A keen runner, he […]
A new study suggests that after genetic matching, the age of a stem cell donor is the most important characteristic influencing patient survival following a stem cell transplant. Previous studies have suggested that donor characteristics including sex, ethnicity, blood type and previous pregnancies could all affect patient survival, making it difficult for transplant clinicians to […]
Stem cell transplant recipients are left feeling like they have “fallen off a cliff”, according to research by charity Anthony Nolan which reveals that one in five are not offered any specialist NHS support during their long-term recovery. Despite transplant patients often being known as “patients for life” due to the long-term side-effects of the […]
Read More… from Stem cell transplant recipients lack specialist support
Researchers are looking for ways eliminate the need for bone marrow donors altogether and instead use different types of cells derived from the patient in need of a transplant, says Dr Vladislav Sandler. At the moment, people who develop leukaemia, lymphoma and other blood diseases often need to undergo a hematopoietic stem cell transplantation (“HSCT”). This […]